Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06330298
Status:
RECRUITING
Last Update Posted:
2024-04-16
First Post:
2023-12-12
Brief Title:
Improving Social Cognition and Social Behaviour in Various Brain Disorders
Sponsor:
University Medical Center Groningen
Organization:
University Medical Center Groningen
Study Overview
Official Title:
Improving Social Cognition and Social Behaviour in Various Brain Disorders
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
T-ScEmo4ALL
Brief Summary:
Impairments in aspects of social cognition are disorder-transcending these have been demonstrated in various neurological disorders such as traumatic brain injury TBI stroke brain tumours both low grade gliomas and meningiomas and multiple sclerosis MS Social cognition involves processing of social information in particular the abilities to perceive social signals understand others and respond appropriately Adolphs 2001 Crucial aspects of social cognition are the recognition of facial expressions of emotions perspective taking also referred to as mentalizing or Theory of Mind and empathy Impairments in social cognition can have a large negative impact on self-care communication social and professional functioning and thus on quality of life of patients
Recently a first multi-faceted treatment for social cognitive impairments in TBI was developed and evaluated T-ScEmo Training Social Cognition and Emotion T-ScEmo turned out to be effective in reducing social cognitive symptoms and improving daily life social functioning in this particular group with effects lasting over time Westerhof-Evers et al 2017 2019
Unfortunately up till now there are no evidence based transdiagnostic treatment possibilities available for these impeding social cognition impairments in neurological patient groups other than TBI Therefore the aim of the present study is to investigate whether T-ScEmo is effective for social cognition disorders in patients with different neurological impairments such as stroke including subarachnoidal haemorrhage SAH brain tumours MS infection meningitis encephalitis and other The secondary objective is to determine which patient related factors are of influence on treatment effectiveness In short hopefully this study can contribute to a treatment possibility for social cognition disorders for all patients with various neurological disorders
It is expected that T-ScEmo will be effective for various neurological disorders based on previous research of Westerhof-Evers et al 2017 2019 Since social cognition disorders within patients with traumatic brain injury do all have the same ethiology it is expected that the treatment will show the same effects for patients with various neurological disorders Therefore it is expected that patients will improve on social cognition social participation and quality of life and social behaviour that these results will last over time
Recently a first multi-faceted treatment for social cognitive impairments in TBI was developed and evaluated T-ScEmo Training Social Cognition and Emotion T-ScEmo turned out to be effective in reducing social cognitive symptoms and improving daily life social functioning in this particular group with effects lasting over time Westerhof-Evers et al 2017 2019
Unfortunately up till now there are no evidence based transdiagnostic treatment possibilities available for these impeding social cognition impairments in neurological patient groups other than TBI Therefore the aim of the present study is to investigate whether T-ScEmo is effective for social cognition disorders in patients with different neurological impairments such as stroke including subarachnoidal haemorrhage SAH brain tumours MS infection meningitis encephalitis and other The secondary objective is to determine which patient related factors are of influence on treatment effectiveness In short hopefully this study can contribute to a treatment possibility for social cognition disorders for all patients with various neurological disorders
It is expected that T-ScEmo will be effective for various neurological disorders based on previous research of Westerhof-Evers et al 2017 2019 Since social cognition disorders within patients with traumatic brain injury do all have the same ethiology it is expected that the treatment will show the same effects for patients with various neurological disorders Therefore it is expected that patients will improve on social cognition social participation and quality of life and social behaviour that these results will last over time
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None